Catheter Precision, Inc. (VTAK)
NYSEAMERICAN: VTAK · IEX Real-Time Price · USD
0.486
-0.004 (-0.82%)
At close: Mar 28, 2024, 4:00 PM
0.510
+0.024 (4.94%)
After-hours: Mar 28, 2024, 5:38 PM EDT

Catheter Precision Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year 2022202120202019201820172016
Cash & Equivalents
15.8615.0523.9114.5864.328.243.92
Short-Term Investments
00015.99000
Cash & Cash Equivalents
15.8615.0523.9130.5864.328.243.92
Cash Growth
5.41%-37.07%-21.82%-52.46%680.81%110.07%-
Receivables
00.020.020.791.320.520.39
Inventory
00.990.882.782.11.20.87
Other Current Assets
0.981.042.811.861.50.090.12
Total Current Assets
16.8417.0927.623669.2310.045.31
Property, Plant & Equipment
03.925.017.894.761.160.51
Other Long-Term Assets
00.040.810.20.050.070.03
Total Long-Term Assets
03.965.828.084.81.230.53
Total Assets
16.8421.0433.4444.0874.0411.275.84
Accounts Payable
0.090.990.471.531.130.430.47
Deferred Revenue
0003.262.492.492.58
Current Debt
00.281.040.610.290.040.04
Other Current Liabilities
7.484.126.251.412.04-0.33-0.39
Total Current Liabilities
7.585.397.766.815.952.632.71
Long-Term Debt
01.983.842.890.560.020.07
Other Long-Term Liabilities
000.691.230.8216.233.45
Total Long-Term Liabilities
01.984.534.121.3816.253.51
Total Liabilities
7.587.3712.2910.937.3318.886.22
Total Debt
02.264.893.50.850.060.11
Debt Growth
--53.65%39.73%311.29%1249.21%-41.12%-
Retained Earnings
-205.14-178.27-153.2-117.16-60.22-29.39-11.62
Comprehensive Income
0000.03000
Shareholders' Equity
9.2613.6721.1533.1566.71-7.62-0.38
Net Cash / Debt
15.8612.7819.0227.0863.478.173.81
Net Cash / Debt Growth
24.08%-32.81%-29.76%-57.33%676.43%114.32%-
Net Cash Per Share
15.34126.54559.772574.248594.931354.21685.85
Working Capital
9.2611.719.8629.1963.287.412.6
Book Value Per Share
8.96135.38622.343151.149033.72-1261.60-68.33
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).